PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma
PTEN缺失和ERBB2/ERBB3介导的AKT再激活导致MET扩增型肝细胞癌对MET抑制剂产生耐药性。
期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-025-01097-y
Qian, Ruolan; Guo, Yuchen; Hu, Xiaolin; Ling, Jing; Geng, Haigang; Ye, Qiaoqiao; Zhang, Linmeng; Zhan, Shujie; Liao, Long; Ge, Yang; Zheng, Quan; Cao, Ying
肿瘤
MET
ERBB3
肿瘤免疫
ERBB2
PTEN
细胞生物学
AKT